Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX)
CAPS Rating:
A biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease.
Investors Helping Investors Beat the Market
A biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
BUSTED ! "potential" already baked into current share price which is much below my entry point. Cut losses and move on. Cleaning up after 2 year hiatus from CAPS.